VIM and infection: Considering that vimentin does not affect HCV cell‐free infection, we employed a strategy of using anti‐E2 nAb in combination with anti‐vimentin Ab to evaluate their impact on HCV cell–cell transmission, to exclude the influence of cell‐free virus (Figure 6C).